Australia, July 28 -- Alnylam Pharmaceuticals Inc., owns the trademark (2635019) for 'SIRELIS' till Jan. 26, 2036.
Status: protected:
Registered/protected
Classes: 40 [Providing technical information in the field of pharmaceutical manufacturing; manufacturing services for others in the field of sirna synthesis; custom manufacture of sirna therapeutics; custom manufacture of rna utilizing proprietary enzymatic technologies to enable nucleic acid therapeutics development.] and 42 [Scientific research and development; research and development of small molecule RNA drugs; research and development of siRNA drugs; RNA interference technology research.]
Type of Mark: Word
Date of Acceptance: April 10
Registration Advertised: July 27
For furt...